Edition:
United Kingdom

Cymabay Therapeutics Inc (CBAY.OQ)

CBAY.OQ on NASDAQ Stock Exchange Global Select Market

5.92USD
4:57pm BST
Change (% chg)

$0.19 (+3.32%)
Prev Close
$5.73
Open
$5.73
Day's High
$5.92
Day's Low
$5.73
Volume
31,631
Avg. Vol
310,379
52-wk High
$14.00
52-wk Low
$4.82

About

CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)

Overall

Beta: 1.15
Market Cap(Mil.): $422.48
Shares Outstanding(Mil.): 68.70
Dividend: --
Yield (%): --

Financials

  CBAY.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -1.31 -- --
ROI: -33.17 7.52 12.69
ROE: -33.47 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates